https://charts.traderzeitung.de/phases/US4330001060 string(1523) "{"isin":"US4330001060","name":"Hims & Hers Health Inc","stock_id_xnas":null,"stock_id_xnys":16776373,"generated_at":"2026-08-23 12:53:00","days":[{"date":"2026-08-19","dst_offset":6,"phases":[{"phase":1,"label":"pre","from":"10:00","to":"15:30","close":27.65,"close_at":"2026-08-19 15:29:00","complete":true,"perf_pct":null},{"phase":2,"label":"regular","from":"15:30","to":"22:00","close":31.095,"close_at":"2026-08-19 21:59:00","complete":true,"perf_pct":12.4593},{"phase":3,"label":"post","from":"22:00","to":"26:00","close":30.71,"close_at":"2026-08-20 01:57:00","complete":true,"perf_pct":-1.2381}]},{"date":"2026-08-20","dst_offset":6,"phases":[{"phase":1,"label":"pre","from":"10:00","to":"15:30","close":30.65,"close_at":"2026-08-20 15:29:00","complete":true,"perf_pct":-0.1954},{"phase":2,"label":"regular","from":"15:30","to":"22:00","close":31.83,"close_at":"2026-08-20 21:59:00","complete":true,"perf_pct":3.8499},{"phase":3,"label":"post","from":"22:00","to":"26:00","close":31.66,"close_at":"2026-08-21 01:46:00","complete":true,"perf_pct":-0.5341}]},{"date":"2026-08-21","dst_offset":6,"phases":[{"phase":1,"label":"pre","from":"10:00","to":"15:30","close":31.78,"close_at":"2026-08-21 15:29:00","complete":true,"perf_pct":0.379},{"phase":2,"label":"regular","from":"15:30","to":"22:00","close":33.8,"close_at":"2026-08-21 21:59:00","complete":true,"perf_pct":6.3562},{"phase":3,"label":"post","from":"22:00","to":"26:00","close":33.65,"close_at":"2026-08-21 23:59:00","complete":true,"perf_pct":-0.4438}]}]}"

Hims & Hers Health Aktie News & Nachrichten

[WKN: A2QMYY | Symbol: HIMS]

Realtimekurs

09.03.2026 um 11 Uhr

Hims & Hers Health

Hims & Hers Health Aktie News & Nachrichten

Vom Gejagten zum Partner! Möglicher Mega-Deal mit Novo Nordisk zündet Kursfeuerwerk bei Hims & Hers!

Doppelschlag für Hims & Hers: SEC-Ermittlungen und schwacher Ausblick schicken Aktie auf Talfahrt

Stocks in Action USA: Kroger, Hims & Hers, STMicroelectronics

Blitz-K.O. vor dem Super Bowl! Hims & Hers stoppt Billig-Wegovy nach massiven Drohungen der FDA!

Super Bowl als Kurskatalysator: Hims & Hers setzt erneut auf maximale Aufmerksamkeit

Hims & Hers: Bringen Kanada-Expansion und Diagnostik-Deal die Trendwende?

Hims & Hers: Telemedizin gewinnt im Winter an zusätzlicher Bedeutung

Hims & Hers: Die Telemedizin-Aktie sollte man nach den jüngsten Quartalszahlen wieder verstärkt im Blick haben!

Hims & Hers: Novo-Deal rückt näher

Diagnostik, Langlebigkeit, Globalisierung – Hims & Hers plant großen Sprung nach vorn

Hims & Hers Health expandiert mit Hormonersatzprogrammen

Hims & Hers profitiert von juristischem Rückenwind im GLP-1-Markt